Home | Welcome to Contract Pharma   
Last Updated Friday, May 29 2015


Topics - Drug Delivery

Refine by Date:
From: To:
Published May 6, 2015
Oral Technologies drive growth in the quarter Read More »
Published May 6, 2015
Expects revenues from device-enabled products to double by 2020 Read More »
Published May 5, 2015
To add commercial spray-drying capacity for inhalation technologies to treat
a wider range of diseases Read More »
Published April 22, 2015
Expands advanced, aseptic, glass-free injectable platform Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 14, 2015
Completes production of a commercial scale lot of EVK-001 in accordance with CMC Read More »
Published April 2, 2015
Partners with Shanghai Sine Promod Pharmaceutical to launch its new Budesonide DPI in China Read More »
Published February 26, 2015
Once-daily basal insulin requires a third of the injection volume as compared to the Lantus SoloSTAR Read More »
Published February 12, 2015
Medication Delivery segment drives growth in the quarter Read More »
Published January 28, 2015
Janssen licenses biopharma candidate employing TRANSINT technology Read More »
Published December 17, 2014
Amunix will receive an option fee and is eligible for additional milestones Read More »
Published December 17, 2014
To develop and commercialize Janssen products with ENHANZE technology Read More »
Published December 4, 2014
Will support the development and reprofiling of zolpidem using Catalent’s OSDrC OptiDose Read More »
Published November 14, 2014
Adds global particle size engineering technologies Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On